We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDMO icon
3701
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-1,956
Closed -$24.2K –
VIRX icon
3702
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$0 ﹤0.01%
8
– –
2018 Q4
25 quarters
HTLF icon
3703
DELISTED
Heartland Financial USA, Inc.
HTLF
– –
-762
Closed -$46.7K –
B icon
3704
DELISTED
Barnes Group Inc.
B
– –
-1,190
Closed -$56.2K –
SMAR icon
3705
DELISTED
Smartsheet Inc.
SMAR
– –
-2,032
Closed -$114K –
GATO
3706
DELISTED
Gatos Silver, Inc.
GATO
– –
-111
Closed -$1.55K –
HYZN icon
3707
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$0 ﹤0.01%
160
– –
2022 Q2
11 quarters
KDNY
3708
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$0 ﹤0.01%
5
– –
2019 Q2
23 quarters
LBPS
3709
DELISTED
4D Pharma PLC
LBPS
$0 ﹤0.01%
+5
New –
2025 Q1
0 quarters
ARCH icon
3710
DELISTED
Arch Resources, Inc.
ARCH
– –
-158
Closed -$22.3K –
IBTX icon
3711
DELISTED
Independent Bank Group, Inc.
IBTX
– –
-8
Closed -$485 –
GEAR
3712
DELISTED
Revelyst, Inc.
GEAR
– –
-44
Closed -$846 –

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.